stars 1 stars 2 stars 3

Asceneuron is a clinical stage biotech company focused on the development of orally bioavailable therapeutics for debilitating neurodegenerative disorders with high unmet medical need. The pipeline reflects our ambition to develop treatments for a wide a range of neurodegenerative diseases including orphan tauopathies, Alzheimer’s and Parkinson’s disease. Asceneuron has two clinical stage small molecule O-GlcNAcase inhibitors in development for the treatment of proteinopathies including Parkinson’s Disease, Alzheimer’s disease and related disorders. Asceneuron is a privately held company financed by a renowned syndicate of investors consisting of Sofinnova Partners, M Ventures, SR One, Johnson & Johnson Innovation – JJDC, Inc. (JJDC) and Kurma Partners. For more information, please visit www.asceneuron.com. Further information: www.asceneuron.com

Website http://www.asceneuron.com/
Revenue $6 million
Employees 9 (3 on RocketReach)
Founded 2012
Address Epfl Innovation Park Bâtiment B, Lausanne CH-1015, CH
Phone +41 21 693 82 42
Technologies
Industry Biotechnology Research, Business Services General, Biotechnology, Orphan Diseases, Business Services, Science and Engineering, Tauopathies, Health Care, Alzheimer's disease, Therapeutics, Small Molecule Drug Discovery, Neurodegeneration, Novel Therapeutics
Web Rank 10 Million
Keywords Neurodegenerative Diseases, Biotech, Drug Development, Neurology, Oral Therapeutics, Clinical Trials, Therapeutics, Unmet Medical Needs, Pharmaceutical, Central Nervous System, Drug Discovery, Bioavailability, Oral Medications, Clinical Stage, Dementia, Rare Diseases, Alzheimers, Parkinsons
Competitors Johnson & Johnson, Roche, Novartis, Merck AH, Sanofi, AstraZeneca, Amgen, Biogen, Pfizer, Lilly India +42 more (view full list)
SIC SIC Code 873 Companies, SIC Code 87 Companies
NAICS NAICS Code 54 Companies, NAICS Code 541714 Companies, NAICS Code 541 Companies, NAICS Code 54171 Companies, NAICS Code 5417 Companies

Asceneuron SA Questions

The Asceneuron SA annual revenue was $6 million in 2026.

Bruno Permanne is the Senior Director, Head of Preclinical Development of Asceneuron SA.

3 people are employed at Asceneuron SA.

The NAICS codes for Asceneuron SA are [54, 541714, 541, 54171, 5417].

The SIC codes for Asceneuron SA are [873, 87].

Top Asceneuron SA Employees

Learn More
How It Works
get free account
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups.
search page
Search the #1 Contact Database
Get contact details of over 700M profiles across 60M companies – all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
get contact page
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2025
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users